Patents by Inventor Hiromu Harada

Hiromu Harada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11979988
    Abstract: Disclosed herein is an electric circuit module that includes a circuit board, an electronic component mounted on an upper surface of the circuit board, and a mold member that covers the upper and side surfaces of the circuit board. The lower area of the side surface of the circuit board is exposed so as not to be covered with the mold member.
    Type: Grant
    Filed: February 14, 2022
    Date of Patent: May 7, 2024
    Assignee: TDK CORPORATION
    Inventors: Shuichi Takizawa, Atsushi Yoshino, Yuki Okino, Hiromu Harada
  • Publication number: 20240136034
    Abstract: There are provided an information processing apparatus, an information processing method, an endoscope system, and a report creation support device which can efficiently input information on a treatment name. The information processing apparatus includes a first processor. The first processor acquires an image captured using an endoscope, displays the acquired image in a first region on a screen of a first display unit, detects a treatment tool from the acquired image, chooses a plurality of treatment names corresponding to the detected treatment tool, displays the plurality of chosen treatment names in a second region on the screen of the first display unit, and accepts selection of one treatment name from among the plurality of displayed treatment names.
    Type: Application
    Filed: January 3, 2024
    Publication date: April 25, 2024
    Applicant: FUJIFILM Corporation
    Inventors: Yuma HORI, Yuya KIMURA, Tatsuya KOBAYASHI, Kenichi HARADA, Goro MIURA, Shungo ASANO, Hiromu SHIMPO
  • Publication number: 20230337371
    Abstract: Disclosed herein is an electronic circuit module that includes a circuit board, an electronic component mounted on an upper surface of the circuit board, and a mold member that covers the upper and side surfaces of the circuit board. The lower area of the side surface of the circuit board is exposed so as not to be covered with the mold member.
    Type: Application
    Filed: June 23, 2023
    Publication date: October 19, 2023
    Inventors: Shuichi TAKIZAWA, Atsushi YOSHINO, Yuki OKINO, Hiromu HARADA
  • Publication number: 20230317540
    Abstract: An electronic circuit package disclosed in the present disclosure includes: a package board having an upper surface, a bottom surface positioned on a side opposite to the upper surface, and a side surface connecting the upper and bottom surfaces; an electronic component mounted on the upper surface of the package board; a first protective layer covering the upper surface of the package board so as to embed therein the electronic component; and a second protective layer covering the side surface of the package board. The first and second protective layers contact each other.
    Type: Application
    Filed: April 4, 2023
    Publication date: October 5, 2023
    Inventors: Shuichi TAKIZAWA, Hiromu HARADA, Atsushi YOSHINO, Yuki OKINO
  • Publication number: 20220302059
    Abstract: Disclosed herein is an electronic component that includes a mounting surface having a terminal formation area and a plurality of terminal electrodes arranged in an array in the terminal formation area. The center point of the terminal formation area is offset with respect to the center point of the mounting surface. Thus, at mounting of the electronic component on a mounting substrate, a solder paste is supplied to a land pattern, and then the mounting is performed such that the center point of a mounting area and the center point of the mounting surface coincide with each other, whereby a predetermined displacement occurs between the planar positions of the land pattern and terminal electrode. This allows a void inside the solder to be released outside without involving a layout change of the land pattern.
    Type: Application
    Filed: March 4, 2022
    Publication date: September 22, 2022
    Inventors: Atsushi YOSHINO, Shuichi TAKIZAWA, Yuki OKINO, Hiromu HARADA
  • Publication number: 20220272842
    Abstract: Disclosed herein is an electric circuit module that includes a circuit board, an electronic component mounted on an upper surface of the circuit board, and a mold member that covers the upper and side surfaces of the circuit board. The lower area of the side surface of the circuit board is exposed so as not to be covered with the mold member.
    Type: Application
    Filed: February 14, 2022
    Publication date: August 25, 2022
    Inventors: Shuichi TAKIZAWA, Atsushi YOSHINO, Yuki OKINO, Hiromu HARADA
  • Patent number: 7402692
    Abstract: The present invention provides novel intermediates represented by general formula (I) etc. for preparing a phenoxyacetic acid derivative represented by general formula (X) or a pharmaceutically acceptable salt thereof, which has ?3-adrenoceptor stimulating activity and are useful for treating or preventing obesity, hyperglycemia, diseases caused by intestinal hypermotility, pollakiuria, urinary incontinence, depression or biliary calculus.
    Type: Grant
    Filed: October 24, 2007
    Date of Patent: July 22, 2008
    Assignee: Kissei Pharmaceutical Co., Ltd.
    Inventors: Nobuyuki Tanaka, Tetsuro Tamai, Harunobu Mukaiyama, Takehiro Ishikawa, Junichi Kobayashi, Satoshi Akahane, Hiromu Harada
  • Patent number: 7396954
    Abstract: The present invention provides novel intermediates represented by general formula (I) etc. for preparing a phenoxyacetic acid derivative represented by general formula (X) or a pharmaceutically acceptable salt thereof, which has ?3-adrenoceptor stimulating activity and are useful for treating or preventing obesity, hyperglycemia, diseases caused by intestinal hypermotility, pollakiuria, urinary incontinence, depression or biliary calculus.
    Type: Grant
    Filed: October 24, 2007
    Date of Patent: July 8, 2008
    Assignee: Kissei Pharmaceutical Co., Ltd.
    Inventors: Nobuyuki Tanaka, Tetsuro Tamai, Harunobu Mukaiyama, Takehiro Ishikawa, Junichi Kobayashi, Satoshi Akahane, Hiromu Harada
  • Patent number: 7393968
    Abstract: The present invention provides novel intermediates represented by general formula (I) etc. for preparing a phenoxyacetic acid derivative represented by general formula (X) or a pharmaceutically acceptable salt thereof, which has ?3-adrenoceptor stimulating activity and are useful for treating or preventing obesity, hyperglycemia, diseases caused by intestinal hypermotility, pollakiuria, urinary incontinence, depression or biliary calculus.
    Type: Grant
    Filed: October 24, 2007
    Date of Patent: July 1, 2008
    Assignee: Kissei Pharmaceutical Co., Ltd.
    Inventors: Nobuyuki Tanaka, Tetsuro Tamai, Harunobu Mukaiyama, Takehiro Ishikawa, Junichi Kobayashi, Satoshi Akahane, Hiromu Harada
  • Publication number: 20080045740
    Abstract: The present invention provides novel intermediates represented by general formula (I) etc. for preparing a phenoxyacetic acid derivative represented by general formula (X) or a pharmaceutically acceptable salt thereof, which has ?3-adrenoceptor stimulating activity and are useful for treating or preventing obesity, hyperglycemia, diseases caused by intestinal hypermotility, pollakiuria, urinary incontinence, depression or biliary calculus. The present invention also provides a process for preparing said intermediates and a method of using said intermediates.
    Type: Application
    Filed: October 24, 2007
    Publication date: February 21, 2008
    Applicant: KISSEI PHARMACEUTICAL CO., LTD.
    Inventors: Nobuyuki TANAKA, Tetsuro Tamai, Harunobu Mukaiyama, Takehiro Ishikawa, Junichi Kobayashi, Satoshi Akahane, Hiromu Harada
  • Publication number: 20080045741
    Abstract: The present invention provides novel intermediates represented by general formula (I) etc. for preparing a phenoxyacetic acid derivative represented by general formula (X) or a pharmaceutically acceptable salt thereof, which has ?3-adrenoceptor stimulating activity and are useful for treating or preventing obesity, hyperglycemia, diseases caused by intestinal hypermotility, pollakiuria, urinary incontinence, depression or biliary calculus. The present invention also provides a process for preparing said intermediates and a method of using said intermediates.
    Type: Application
    Filed: October 24, 2007
    Publication date: February 21, 2008
    Applicant: KISSEI PHARMACEUTICAL CO., LTD.
    Inventors: Nobuyuki Tanaka, Tetsuro Tamai, Harunobu Mukaiyama, Takehiro Ishikawa, Junichi Kobayashi, Satoshi Akahane, Hiromu Harada
  • Publication number: 20080045739
    Abstract: The present invention provides novel intermediates represented by general formula (I) etc. for preparing a phenoxyacetic acid derivative represented by general formula (X) or a pharmaceutically acceptable salt thereof, which has ?3-adrenoceptor stimulating activity and are useful for treating or preventing obesity, hyperglycemia, diseases caused by intestinal hypermotility, pollakiuria, urinary incontinence, depression or biliary calculus. The present invention also provides a process for preparing said intermediates and a method of using said intermediates.
    Type: Application
    Filed: October 24, 2007
    Publication date: February 21, 2008
    Applicant: KISSEI PHARMACEUTICAL CO., LTD
    Inventors: Nobuyuki Tanaka, Tetsuro Tamai, Harunobu Mukaiyama, Takehiro Ishikawa, Junichi Kobayashi, Satoshi Akahane, Hiromu Harada
  • Patent number: 7329771
    Abstract: The present invention provides novel intermediates represented by general formula (I) etc. for preparing a phenoxyacetic acid derivative represented by general formula (X) or a pharmaceutically acceptable salt thereof, which has ?3-adrenoceptor stimulating activity and are useful for treating or preventing obesity, hyperglycemia, diseases caused by intestinal hypermotility, pollakiuria, urinary incontinence, depression or biliary calculus. The present invention also provides a process for preparing said intermediates and a method of using said intermediates.
    Type: Grant
    Filed: September 5, 2002
    Date of Patent: February 12, 2008
    Assignee: Kissei Pharmaceuticals Co., Ltd.
    Inventors: Nobuyuki Tanaka, Tetsuro Tamai, Harunobu Mukaiyama, Takehiro Ishikawa, Junichi Kobayashi, Satoshi Akahane, Hiromu Harada
  • Patent number: 7208520
    Abstract: The present invention provides ethyl (?)-2-[4-[2-[[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]-2,5-dimethylphenoxy]acetate hydrochloride, crystalline forms thereof and pharmaceutical compositions containing them, which have excellent ?3-adrenoceptor stimulating effects, therapeutic effects on pollakiuria or urinary incontinence and storage stabilities and are useful as a medicament.
    Type: Grant
    Filed: August 27, 2002
    Date of Patent: April 24, 2007
    Assignee: Kissei Pharmaceutical Co., Ltd.
    Inventors: Hidetoshi Isawa, Yukihiko Hotei, Kiyoshi Kasai, Junichi Sonehara, Satoshi Akahane, Hiromu Harada
  • Publication number: 20060135605
    Abstract: The present invention provides novel intermediates represented by general formula (I) etc. for preparing a phenoxyacetic acid derivative represented by general formula (X) or a pharmaceutically acceptable salt thereof, which has ?3-adrenoceptor stimulating activity and are useful for treating or preventing obesity, hyperglycemia, diseases caused by intestinal hypermotility, pollakiuria, urinary incontinence, depression or biliary calculus. The present invention also provides a process for preparing said intermediates and a method of using said intermediates.
    Type: Application
    Filed: September 5, 2002
    Publication date: June 22, 2006
    Inventors: Nobuyuki Tanaka, Tetsuro Tamai, Harunobu Mukaiyama, Takehiro Ishikawa, Junichi Kobayashi, Satoshi Akahane, Hiromu Harada
  • Publication number: 20040242686
    Abstract: The present invention provides ethyl (−)-2-[4-[2-[[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]-2,5-dimethylphenoxy]acetate hydrochloride, crystalline forms thereof and pharmaceutical compositions containing them, which have excellent &bgr;3-adrenoceptor stimulating effects, therapeutic effects on pollakiuria or urinary incontinence and storage stabilities and are useful as a medicament.
    Type: Application
    Filed: March 12, 2004
    Publication date: December 2, 2004
    Inventors: Hidetoshi Isawa, Yukihiko Hotei, Kiyoshi Kasai, Junichi Sonehara, Satoshi Akahane, Hiromu Harada
  • Patent number: 5861437
    Abstract: A poly(phenylene ether) resin composed of structural units represented by the general formula: ##STR1## (wherein R.sup.1, R.sup.2 and R.sup.3 represent each alkyl, cycloalkyl, etc. or H (provided that two or more of R.sup.1, R.sup.2 and R.sup.3 do not represent H at the same time), or one of R.sup.1, R.sup.2 and R.sup.3 represents alkyl or H while the others together form a saturated ring, or R.sup.1, R.sup.2 and R.sup.3 together form an aromatic ring; A represents alkyl; p is an integer of from 3 to 5; and Y.sup.- represents a pharmaceutically acceptable acid residue) and/or structural units represented by the general formula: ##STR2## (wherein R.sup.4, R.sup.5 and R.sup.6 represents each alkyl, cycloalkyl, etc. or H (provided that two or more of R.sup.4, R.sup.5 and R.sup.6 do not represent H at the same time), or one of R.sup.4, R.sup.5 and R.sup.6 represents alkyl or H while the others together form a saturated ring, or R.sup.4, R.sup.5 and R.sup.6 together form an aromatic ring; and A, p and Y.sup.
    Type: Grant
    Filed: October 7, 1997
    Date of Patent: January 19, 1999
    Assignee: Kissei Pharmaceutical Company, Ltd.
    Inventors: Hiromu Harada, Yukihiko Hotei, Hideki Hujikura, Yoshinori Nonaka, Koji Kamata, Mitsuhiro Ichihara, Hiroshi Kusama, Humiyasu Satoh
  • Patent number: 5294718
    Abstract: Piperidino-3,4-dihydrocarbostyril compounds represented by the formula: ##STR1## wherein R.sup.1 represents a hydroxy group or an acyloxy group having 2 to 11 carbon atoms; one of R.sup.2 and R.sup.3 represents a nitro group, a cyano group, an alkoxycarbonyl group having 2 to 7 carbon atoms, an alkyl group having 1 to 4 carbon atoms, a haloalkyl group having 1 to 3 carbons atoms, or a halogen atom, and the other represents a hydrogen atom; and pharmaceutically acceptable salts thereof, exhibit platelet aggregation inhibiting activity and thus being useful as therapeutic agents for the prevention or treatment of cerebral ischemic disorders and arterial ischemic disorders.
    Type: Grant
    Filed: August 3, 1993
    Date of Patent: March 15, 1994
    Assignee: Kissei Pharmaceutical Co., Ltd.
    Inventors: Arao Ujiie, Hiromu Harada, Akira Iyobe, Masahiko Uchida, Koji Kamata
  • Patent number: 5023261
    Abstract: Benzofuro[3,2-c]quinoline compounds of the general formula: ##STR1## wherein (1) each of R.sup.1 and R.sup.2 is the same, and represent a group of the formula of --OR.sup.3 in which R.sup.3 represents a carbamoyl group, an N-mono-alkylcarbamoyl group, an N,N-dialkylcarbamoyl group, an alkylsulfonyl group, a formyl group or an aliphatic acyl group which may have an alkoxycarbonyl group as a substituent; m represents zero, 1 or 2; n represents zero or 1; with the proviso that n is not zero when m is zero,(2) each of R.sup.1 and R.sup.2 is different, and represent a hydroxy group or an N,N-di-alkylcarbamoyloxy group; m represents 1 or 2; n represents 1, possess a strong inhibitory action on bone resorption and a stimulatory effect on ossification. Some benzofuro[3,2-c]quinoline compounds of the above general formula also possess a stimulatory effect on longitudinal bone growth, and thus are useful for the prevention or treatment of osteoporosis.
    Type: Grant
    Filed: March 9, 1989
    Date of Patent: June 11, 1991
    Assignee: Kissei Pharmaceutical Co., Ltd.
    Inventors: Tetsuhide Kamijo, Arao Ujiie, Hiromu Harada, Naoyuki Tsutsumi, Atsushi Tsubaki, Toshiaki Yamaguchi, Hideo Nagata
  • Patent number: 4623724
    Abstract: The present invention provides an improved method for producing a nuclear substituted cinnamoylanthranilic acid compound.Illustrative of the process is the reaction of 3,4-dimethoxybenzaldehyde with 2-carboxymalonanilic acid in an inert solvent medium in the presence of piperidine to provide an intermediate salt precipitate, and the salt is treated with an acidic reagent to yield N-(3,4-dimethoxycinnamoyl)anthranilic acid product.
    Type: Grant
    Filed: August 14, 1984
    Date of Patent: November 18, 1986
    Assignee: Kissei Pharmaceutical Co., Ltd.
    Inventors: Kinji Iizuka, Tetsuhide Kamijo, Ryoji Yamamoto, Hiromu Harada